“Bispecific Antibodies” — FilingIndex Search

Filter

50 of 3,901

Sort

JNJJOHNSON & JOHNSON🔥

Healthcare · Pharmaceuticals

$579.83B-1.8%

P/E 27.6·P/S 6.0·Mgn 21.8%·ROE 32.9%·FCF 3.4%

F 4

AZNASTRAZENECA PLC🔥

Healthcare · Pharmaceuticals

$277.22B-0.7%

P/E 46.5·P/S 6.1·Mgn 13.0%·ROE 21.0%·FCF 4.2%

—

BIIBBIOGEN INC.

Healthcare · Biotechnology

$29.53B-0.3%

P/E 21.5·P/S 3.0·Mgn 13.8%·ROE 7.1%·FCF 6.9%

F 5

13D

JAZZJazz Pharmaceuticals plc

Healthcare · Pharmaceuticals

$14.48B+1.4%

P/E 25.9·P/S 3.6·Mgn 13.8%·ROE -8.2%·FCF 9.0%

—

Red 8-K

EXELEXELIXIS, INC.

Healthcare · Biotechnology

$13.35B+0.2%

P/E 25.6·P/S 6.2·Mgn 24.0%·ROE 36.2%·FCF 6.6%

F 6

Red 8-K

SMMTSummit Therapeutics Inc.

Healthcare · Pharmaceuticals

$10.87B+1.8%

P/E —·P/S —·Mgn —·ROE -163.9%·FCF —

—

HALOHALOZYME THERAPEUTICS, INC.

Healthcare · Biotechnology

$8.24B+1.4%

P/E 23.6·P/S 5.5·Mgn 23.1%·ROE 649.2%·FCF 7.8%

F 5

Red 8-K

PTGXProtagonist Therapeutics, Inc

Healthcare · Pharmaceuticals

$7.06B+0.8%

P/E —·P/S 95.3·Mgn -154.9%·ROE -21.2%·FCF 0.8%

—

Red 8-K

SYRESpyre Therapeutics, Inc.

Healthcare · Pharmaceuticals

$7.02B-1.5%

P/E —·P/S —·Mgn —·ROE -21.7%·FCF —

—

13DRed 8-K

SRRKScholar Rock Holding Corp

Healthcare · Biotechnology

$5.29B+0.1%

P/E —·P/S —·Mgn —·ROE -154.0%·FCF -5.7%

—

CAICaris Life Sciences, Inc.

Healthcare · Healthcare Services

$5.08B-2.7%

P/E 149.5·P/S 5.6·Mgn 3.7%·ROE -11.8%·FCF 1.3%

—

ERASErasca, Inc.

Healthcare · Pharmaceuticals

$4.37B+0.2%

P/E —·P/S —·Mgn —·ROE -38.3%·FCF —

—

KNSAKiniksa Pharmaceuticals International, plc

Healthcare · Pharmaceuticals

$3.99B+2.5%

P/E 54.6·P/S 5.3·Mgn 9.7%·ROE 10.4%·FCF 3.4%

F 7

13DRed 8-K

DNLIDenali Therapeutics Inc.

Healthcare · Biotechnology

$3.44B-0.7%

P/E —·P/S —·Mgn —·ROE -50.6%·FCF -12.3%

—

CLDXCelldex Therapeutics, Inc.

Healthcare · Diagnostics & Tools

$2.45B-0.6%

P/E —·P/S 1588.6·Mgn -16748.0%·ROE -49.1%·FCF -8.7%

F 1

Red 8-K

KODKodiak Sciences Inc.

Healthcare · Biotechnology

$2.13B+3.2%

P/E —·P/S —·Mgn —·ROE -146.1%·FCF —

—

ZLABZai Lab Ltd

Healthcare · Pharmaceuticals

$1.92B+3.2%

P/E —·P/S 4.2·Mgn -39.3%·ROE -24.5%·FCF -8.3%

F 3

Red 8-K

VRDNViridian Therapeutics, Inc.DE

Healthcare · Pharmaceuticals

$1.81B-2.2%

P/E —·P/S 25.5·Mgn -483.6%·ROE -47.4%·FCF -15.3%

—

13D

BHVNBiohaven Ltd.⚡

Healthcare · Pharmaceuticals

$1.70B-0.5%

P/E —·P/S 2.0·Mgn -108.3%·ROE -1418.8%·FCF —

—

ZYMEZymeworks Inc.

Healthcare · Pharmaceuticals

$1.68B+8.5%

P/E —·P/S 20.7·Mgn -126.3%·ROE -30.2%·FCF -2.1%

—

BCAXBicara Therapeutics Inc.

Healthcare · Pharmaceuticals

$1.43B+1.2%

P/E —·P/S —·Mgn —·ROE -34.4%·FCF —

—

AVBPArriVent BioPharma, Inc.

Healthcare · Pharmaceuticals

$1.42B+1.1%

P/E —·P/S —·Mgn —·ROE -54.1%·FCF —

—

COAGHemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

$1.17B0.0%

P/E —·P/S —·Mgn —·ROE —·FCF —

—

13DRed 8-K

XNCRXencor Inc

Healthcare · Pharmaceuticals

$914M+3.2%

P/E —·P/S 9.4·Mgn -177.1%·ROE -14.5%·FCF -15.1%

—

Red 8-K

JANXJanux Therapeutics, Inc.

Healthcare · Pharmaceuticals

$827M+0.2%

P/E —·P/S 60.2·Mgn -833.6%·ROE -11.9%·FCF -10.1%

—

Red 8-K

AVTXAvalo Therapeutics, Inc.

Healthcare · Pharmaceuticals

$776M-4.2%

P/E —·P/S —·Mgn —·ROE -94.2%·FCF —

—

Dilut.Red 8-K

ALLOAllogene Therapeutics, Inc.

Healthcare · Biotechnology

$656M-6.3%

P/E —·P/S —·Mgn —·ROE -65.3%·FCF -22.8%

—

Red 8-K

CTMXCytomX Therapeutics, Inc.

Healthcare · Pharmaceuticals

$655M+0.3%

P/E —·P/S 18.4·Mgn -166.4%·ROE -17.5%·FCF -11.6%

—

Red 8-K

CLYMClimb Bio, Inc.

Healthcare · Pharmaceuticals

$655M-2.4%

P/E —·P/S —·Mgn —·ROE -37.3%·FCF —

—

13DDilut.Red 8-K

ACRSAclaris Therapeutics, Inc.

Healthcare · Pharmaceuticals

$603M+5.4%

P/E —·P/S 72.1·Mgn -832.6%·ROE -63.0%·FCF -7.8%

F 2

CBIOCRESCENT BIOPHARMA, INC.

Healthcare · Pharmaceuticals

$494M0.0%

P/E —·P/S 41.6·Mgn -782.5%·ROE -75.8%·FCF -14.7%

—

CABACabaletta Bio, Inc.

Healthcare · Biotechnology

$491M0.0%

P/E —·P/S —·Mgn —·ROE -149.8%·FCF —

—

ARVNARVINAS, INC.

Healthcare · Pharmaceuticals

$489M+0.2%

P/E —·P/S 6.2·Mgn -467.9%·ROE -18.6%·FCF -56.4%

—

Red 8-K

STROSUTRO BIOPHARMA, INC.

Healthcare · Biotechnology

$477M-0.5%

P/E —·P/S 4.8·Mgn -154.2%·ROE —·FCF —

—

STTKShattuck Labs, Inc.

Healthcare · Pharmaceuticals

$472M+1.3%

P/E —·P/S 471.8·Mgn -4987.4%·ROE -59.2%·FCF -8.5%

—

13DRed 8-K

CCCCC4 Therapeutics, Inc.

Healthcare · Biotechnology

$431M+7.4%

P/E —·P/S 12.0·Mgn -292.1%·ROE -40.9%·FCF -23.0%

—

Red 8-K

CMPXCompass Therapeutics, Inc.

Healthcare · Biotechnology

$366M+1.4%

P/E —·P/S —·Mgn —·ROE -33.8%·FCF -13.4%

—

GLSIGreenwich LifeSciences, Inc.

Healthcare · Pharmaceuticals

$353M+0.9%

P/E —·P/S —·Mgn —·ROE -5480.5%·FCF —

—

ZURAZura Bio Ltd

Healthcare · Biotechnology

$351M+4.8%

P/E —·P/S —·Mgn —·ROE -67.6%·FCF —

—

Red 8-K

LYELLyell Immunopharma, Inc.

Healthcare · Pharmaceuticals

$315M+10.2%

P/E —·P/S —·Mgn —·ROE -110.6%·FCF -47.9%

—

MGNXMACROGENICS INC

Healthcare · Pharmaceuticals

$252M-4.9%

P/E —·P/S 1.6·Mgn -44.8%·ROE -134.2%·FCF -33.0%

F 3

CHRSCoherus Oncology, Inc.

Healthcare · Biotechnology

$216M-3.5%

P/E —·P/S 0.1·Mgn -0.5%·ROE 275.4%·FCF —

F 6

Red 8-K

WHWKWhitehawk Therapeutics, Inc.

Healthcare · Pharmaceuticals

$206M+3.9%

P/E —·P/S 28.8·Mgn -288.3%·ROE -15.1%·FCF -47.6%

F 4

13DDilut.

CGENCOMPUGEN LTD

Healthcare · Biotechnology

$193M-0.9%

P/E —·P/S —·Mgn —·ROE 34.4%·FCF 16.2%

F 7

CRBUCaribou Biosciences, Inc.

Healthcare · Biotechnology

$158M-0.6%

P/E —·P/S 14.2·Mgn -1327.4%·ROE -121.2%·FCF -71.0%

—

AGENAGENUS INC

Healthcare · Biotechnology

$137M-2.9%

P/E 2.2·P/S 1.1·Mgn 50.5%·ROE —·FCF -56.2%

F 4

Red 8-K

KLRSKalaris Therapeutics, Inc.

Healthcare · Biotechnology

$103M-3.4%

P/E —·P/S —·Mgn —·ROE —·FCF -19.9%

—

13DRed 8-K

IBIOiBio, Inc.

Healthcare · Pharmaceuticals

$84M+1.2%

P/E —·P/S —·Mgn —·ROE -123.5%·FCF -18.2%

—

Red 8-K

INKTMiNK Therapeutics, Inc.

Healthcare · Biotechnology

$60M-1.9%

P/E —·P/S —·Mgn —·ROE —·FCF —

—

TILInstil Bio, Inc.

Healthcare · Biotechnology

$54M+2.1%

P/E —·P/S —·Mgn —·ROE -62.7%·FCF —

—

Red 8-K

Filings · filterAll 10-K 10-Q 8-K S-1 DEF 14A SC 13D

Filings

40 shown

BPREBluerock Private Real Estate Fund

DEF 14A

Proxy statement — executive pay, board nominees, and shareholder votes.

Jun 30, 2026·18h ago

CYCUWCycurion, Inc.

DEF 14A

Proxy statement — executive pay, board nominees, and shareholder votes.

Companies above the $50M market cap · $1 pricefloor; SPAC/shells hidden by default. Fundamentals & prices via Polygon · signals from SEC EDGAR — verify on SEC.gov. Filings current to Jun 30 · prices to Jun 30.